Sofosbuvir and other anti-infective agents such as azithromycin, which may be administered during gestation, have shown efficacy in the treatment of zika, could be implemented in regions of high prevalence of congenital syndrome by zika to try to curb infants affected by microcephaly and Other teratogenic affections?